Empirical versus preemptive antimycotic therapy in terms of outcome benefit

Ítems similars

• Efficacy and utility of preemptive anti-Gr(+) coverage in selected critically ill patients
  per: Todorova, VT, et al.
  Publicat: (2013)
• Efficacy and utility of a protocol for pre-emptive antimycotic therapy
  per: Milanov, SG, et al.
  Publicat: (2010)
• Fungal infections in the intensive care unit? Another approach for defining a target group of patients who benefit from implementing preemptive antimycotic treatment
  per: Geube, M, et al.
  Publicat: (2007)
• Determinants of ventilator weaning outcome in a medical-surgical ICU
  per: Georgiev, G, et al.
  Publicat: (2014)
• Gram-positive nosocomial infections in a general ICU: emerging new clues
  per: Milanov, S, et al.
  Publicat: (2011)